Rapport Therapeutics (RAPP) Asset Utilization Ratio (2026)
Powered by 
Analysis
Rapport Therapeutics (RAPP) Asset Utilization Ratio (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.13 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 0.54 |
| 10 | Rapport Therapeutics | 2.22 Bn | 2.22 Bn | - | 0.04 |